Protocolized Regional Citrate Anticoagulation during Continuous Renal Replacement Therapy: A Single Center Experience-Reference-Cited by-同舟云学术

Protocolized Regional Citrate Anticoagulation during Continuous Renal Replacement Therapy: A Single Center Experience

Published:2024-08-31 Issue:9 Volume:28 Page:859-865
ISSN:0972-5229
Container-title:Indian Journal of Critical Care Medicine
language:en
Short-container-title:

Author:

Chandra Subhash,Jagadeesh KN,Pal Divya,Pattajoshi Swagat,Govil Deepak,Harne Rahul,Patel Sweta J,Kumar G Praveen,Pachisia Anant V,Tyagi Pooja,Brar Keerti,Patel Parimal B,Zatakiya Ronak

Publisher

Jaypee Brothers Medical Publishing

Link

https://www.ijccm.org/doi/pdf/10.5005/jp-journals-10071-24797

Reference24 articles.

1. 1. Venkataraman R, Kellum JA, Palevsky P. Dosing patterns for continuous renal replacement therapy at a large academic medical centre in the United States. J Crit Care 2002;17(4):246. DOI: 10.1053/jcrc.2002.36757.

2. 2. Davenport A, Will EJ, Davison AM. Comparison of the use of standard heparin and prostacyclin anticoagulation in spontaneous and pump-driven extracorporeal circuits in patients with combined acute renal and hepatic failure. Nephron 1994;66(4):431–437. DOI: 10.1159/000187859.

3. 3. Martin PY, Chevrolet JC, Suter P, Favre H. Anticoagulation in patients treated by continuous venovenous hemofiltration: A retrospective study. Am J Kidney Dis 1994;24(5):806–812. DOI: 10.1016/s0272-6386(12)80675-5.

4. 4. van de Wetering J, Westendorp RG, van der Hoeven JG, Stolk B, Feuth JD, Chang PC. Heparin use in continuous renal replacement procedures: The struggle between filter coagulation and patient hemorrhage. J Am Soc Nephrol 1996;7(1):145–150. DOI: 10.1681/ASN.V71145.

5. 5. Calatzis A, Toepfer M, Schramm W, Spannagl M, Schiffl H. Citrate anticoagulation for extracorporeal circuits: Effects on whole blood coagulation activation and clot formation. Nephron 2001;89(2):233–236. DOI: 10.1159/000046075.